Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
01 Feb 2017 Nature Reviews Clinical Oncology – Year in Review Genitourinary cancers - Haematologic malignancies - Endocrine and neuroendocrine tumours - Sarcomas - Lung and other thoracic tumours - Head and neck cancers
31 Jan 2017 Withdrawal of the Application for a Change to the Marketing Authorisation for Denosumab Palliative and supportive care
30 Jan 2017 EMA Recommends Extension of Indications for Lenalidomide in Multiple Myeloma Haematologic malignancies - Anticancer agents & Biologic therapy
27 Jan 2017 NICE Issues Technology Appraisal Guidance for Ibrutinib for Previously Treated CLL and Untreated CLL with 17p Deletion or TP53 Mutation Haematologic malignancies - Anticancer agents & Biologic therapy
26 Jan 2017 Nivolumab as Salvage Therapy in Pretreated Patients with Advanced Gastric or Gastro-oesophageal Junction Cancer Gastrointestinal cancers - Cancer Immunology and Immunotherapy
25 Jan 2017 NICE Issues Recommendations for Pomalidomide in Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib Haematologic malignancies - Anticancer agents & Biologic therapy
23 Jan 2017 Ibrutinib, First FDA-Approved Therapy for Marginal Zone Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
17 Jan 2017 FDA Approves Bevacizumab Plus Chemotherapy, Followed by Bevacizumab Alone, for the Treatment of Patients with Platinum-Sensitive Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
16 Jan 2017 FDA Grants Priority Review for Atezolizumab in First-Line Treatment of Patients With Urothelial Carcinoma Who are Not Eligible for Cisplatin Chemotherapy Genitourinary cancers - Cancer Immunology and Immunotherapy
13 Jan 2017 Tailored Scientific Advice to Support Step-by-Step Development of New Biosimilars Bioethics, legal and economic issues
12 Jan 2017 NICE Issues Recommendations for Pembrolizumab in PD-L1-positive Locally Advanced or Metastatic NSCLC After Chemotherapy Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
10 Jan 2017 EU-funded MoTriColor Project for Patients with Metastatic CRC Translational research - Gastrointestinal cancers
09 Jan 2017 NICE Recommends Pertuzumab for the Neoadjuvant Treatment of HER2-positive Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
23 Dec 2016 EMA Adopts a New Indication for 5-Aminolevulinic Acid Melanoma and other skin tumours - Anticancer agents & Biologic therapy